Fractured Truth Campaign Wins Bronze Pearl Award for Content Marketing Excellence in the Healthcare/Pharmaceutical Industry
December 11 2017 - 1:30PM
Radius Health, Inc. (Nasdaq:RDUS) today announced that Fractured
Truth—an unbranded patient campaign aimed to educate younger
postmenopausal women about risks associated with osteoporosis—won
the Bronze Healthcare/Pharmaceutical Industry Pearl Award at the
Content Council 2017 Pearl Awards and Winter Conference in New York
City.
"We are extremely pleased to receive this important recognition
among our marketing peers," said Kate Hermans, Vice President of
Marketing, Radius Health. "There remains a great need to educate
patients about the serious health concerns related to
osteoporosis—a condition of enlarged bone spaces from decreasing
estrogen levels, along with increased bone porosity and fragility.
It is also important that the link between fractures and
postmenopausal osteoporosis is addressed."
The Fractured Truth campaign was created to literally fracture
the common misconceptions around osteoporosis, educate women on the
facts, and urge them to speak with their doctor about the
seriousness of such an undervalued and underappreciated condition.
The multichannel, hyper-targeted campaign purposefully took a
content strategy approach to reach women and captured their
attention with explosive imagery and provocative messaging to
elevate the conversation around bone health.
The campaign has reached over 3.5 million people, and the
message is getting through. Women are actively sharing the content
with friends, commenting on social media, and talking to their
doctor. When asked what message they took away from the campaign,
urgency to treat ranked highest.
The Pearl Awards are presented by the Content Council, the
premier non-profit organization representing content marketers
globally. Since the first Pearl Awards were held in 2004, they have
been universally recognized as the industry standard bearer for
content marketing awards and are held in New York City every
year.
The Pearl Award is the third recognition that Radius has
received within the last several weeks. Honors include:
- 2017 Rx Club Awards: Rethink Osteoporosis, the unbranded
professional campaign, won a Silver Award for Envelope
Mailer/Campaign and Awards of Excellence for Posters/Announcements
& Professional Education/Campaigns. The Fractured Truth
campaign won Awards of Excellence for Best Consumer Website — Other
(unbranded) & Integrated Campaigns — Launch Campaigns.
- Clio Health Awards: The Rethink Osteoporosis campaign was
shortlisted for Poster Design & Art Direction in Print
Technique.
As an emerging leader in osteoporosis, Radius Health has been
partnering with healthcare practitioners, professional
organizations, advocates, and women living with osteoporosis to
help close the awareness, diagnosis and treatment gaps through
these campaigns. The Company is fully committed to providing
education to help enhance the understanding of the diagnosis,
treatment, and management of patients with osteoporosis.
On behalf of the Executive Leadership Team, congratulations to
the Radius Marketing Team for this impressive recognition.
About Postmenopausal Osteoporosis
Osteoporosis is a silent disease, often displaying no signs or
symptoms until a fracture occurs, leaving a majority of patients
undiagnosed and undertreated. Osteoporotic fractures create a
significant healthcare burden, and represent a significant unmet
medical need. The majority of osteoporosis-related fractures in the
U.S. among those 50 and older (71 percent) occur in women.
The National Osteoporosis Foundation (NOF) has estimated that
nearly 8.2 million women in the U.S. over the age of 50 have
osteoporosis, and nearly one in two women over the age of 50 will
have a fragility fracture (or low-impact fracture that is often the
result of a fall from standing height or lower) in her remaining
lifetime.
The annual incidence of osteoporotic fractures is higher than
that of stroke, heart attack and breast cancer combined;
osteoporotic fractures also account for more hospitalizations and
associated costs than cardiovascular disease and breast
cancer.
About Radius
Radius is a science-driven fully integrated biopharmaceutical
company that is committed to developing and commercializing
innovative therapeutics in the areas of osteoporosis, oncology and
endocrine diseases. For more information, please visit
www.radiuspharm.com.
Media Relations Contact: Tiffany H. Burke
Email: tburke@radiuspharm.com Phone: 484-582-6476
Radius Recycling (NASDAQ:RDUS)
Historical Stock Chart
From Apr 2024 to May 2024
Radius Recycling (NASDAQ:RDUS)
Historical Stock Chart
From May 2023 to May 2024